[翻译文章] 过,抗胆固醇药物和痴呆症
J Del Boz1, J C Bautista Vidal2
1Servicio de Dermatología, Hospital Regional Universitario de Málaga, Málaga, Spain.
Actas dermo-sifiliograficas
|July 22, 2025
概括
口服抗胆固醇药有效治疗过,但可能与痴呆风险有关. 本综述探讨了抗胆固醇药物用于过和痴呆症发展之间的有争议的联系.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 口服抗胆固醇药物被广泛用于超治疗的非标签药物,其已证明有效性和一般有利的安全性.
- 最近的研究将抗胆固醇使用,特别是老年人,与痴呆症风险增加联系在一起.
- 一些研究表明,过本身可能是痴呆症的早期指标.
研究的目的:
- 为了调查口服抗胆固醇剂在过症和痴呆症的发展之间潜在的关联.
- 审查关于这个有争议和研究不足的主题的当前数据.
主要方法:
- 现有研究和临床试验数据对抗胆固醇药物用于过的审查.
- 分析了与抗胆固醇药物与痴呆风险相关的研究结果.
- 检查研究建议过症作为痴呆症的潜在早期症状的研究.
主要成果:
- 证据支持口服抗胆固醇药对超的有效性和安全性.
- 许多研究将抗胆固醇使用与痴呆症联系起来,特别是在老年人群中.
- 没有任何特定的研究直接将抗胆固醇治疗过症与痴呆症发展联系起来.
结论:
- 对抗胆固醇药物用于过和痴呆的潜在联系仍然是一个需要进一步研究的领域.
- 临床医生应考虑潜在的风险和益处,在处方抗胆药物治疗超症时,特别是在风险人群中.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Therapeutic Uses
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


